Deusitrelvir

德赛特韦

Report date: 2024/05/15 15:52:12
NME

Base Information

Drug NameDeusitrelvir
Drug Alias NameDesetavirSHEN-211SHEN211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHubei JKT BioPharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJKT Biopharma Co LtdHubei JKT BioPharma Co Ltd
Inactive CompaniesJointown Pharmaceutical Group Co Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A